| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |